Indium-111 labelled lymphocytes: Isotope distribution and cell division

被引:0
|
作者
Kuyama, J
McCormack, A
George, AJT
Heelan, BT
Osman, S
Batchelor, JR
Peters, AM
机构
[1] ROYAL POSTGRAD MED SCH,DEPT RADIOL,LONDON,ENGLAND
[2] ROYAL POSTGRAD MED SCH,DEPT IMMUNOL,LONDON,ENGLAND
[3] ROYAL POSTGRAD MED SCH,MRC,CYCLOTRON UNIT,LONDON,ENGLAND
来源
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1997年 / 24卷 / 05期
关键词
indium-111 labelled lymphocytes; fluorine-18; fluorodeoxyglucose;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Since lymphocytes continue to proliferate and divide in vivo, it is important to determine the fate of a radionulide following lymphocyte labelling. Using the mixed lymphocyte reaction (MLR), we induced indium-111 labelled lymphocytes from a specific in-bred rat strain (AS) to divide and then observed the subsequent In-111 distribution between cells and supernatant. L10 and L12.4 cells, which are allospecific CD4+ T lymphocytes from the AS rat, were stimulated in the MLR by antigen-presenting cells from the August rat, a different strain. We labelled L10 or L12.4 lymphocytes on day 0, the first day of the stimulation cycle, and continued to culture the lymphocytes in vitro. The proliferation of the cells was estimated according to their increase in number. The distribution of In-111 between cell and supernatant fractions and between viable and dead (but intact) cells was measured in the cell suspension each day after labelling. The metabolic activity of In-111-labelled lymphocytes was compared with control cells by measuring their uptake of fluorine-18 fluorodeoxyglucose ([F-18]FDG). In-111-labelled lymphocytes showed a poor proliferative response compared with control cells 24-48 h after labelling but increased in number after this time. From 24 to 72 h, about 70% of In-111 was in the supernatant but only about 5%-10% was associated with intact dead cells. These dead cells tended to retain their In-111, losing less than 30% per day, suggesting that In-111 in the supernatant was the result of active elimination from viable cells, Moreover, 24 h after culture, considerably more In-111 was associated with viable than with dead lymphocytes, although over the next few days this distribution reversed. In-111-labelled lymphocytes took up more [F-18]FDG than control cells at 24 h but not at 0 or 72-96 h; the maximum [F-18]FDG uptake coincided with the greatest reduction in cell number. Furthermore, [F-18]FDG uptake correlated with the initial In-111 burden in lymphocytes labelled with In-111 24 h previously. The results are consistent with active elimination of In-111 by In-111-labelled lymphocytes. The energy requirements for this are diverted away from cell division, thereby increasing the probability of cell death, As lymphocytes become In-111 deplete, they recover their capacity to proliferate and their risk of death decreases, These findings have important implications for In-111-labelled lymphocyte scintigraphy, suggesting that cells remaining viable immediately after labelling will either subsequently die or alternatively eliminate the label.
引用
收藏
页码:488 / 496
页数:9
相关论文
共 50 条
  • [41] INDIUM-111 BLEOMYCIN AS A TUMOR SCANNING AGENT IN PEDIATRIC ONCOLOGY
    OMARA, RE
    HABER, K
    CORRIGAN, J
    JOHNSON, H
    LILIEN, DL
    JOURNAL OF NUCLEAR MEDICINE, 1975, 16 (06) : 554 - 554
  • [42] METHODS FOR COMPACT CYCLOTRON PRODUCTION OF INDIUM-111 FOR MEDICAL USE
    MACDONALD, NS
    NEELY, HH
    WOOD, RA
    TAKAHASHI, JM
    WAKAKUWA, SI
    BIRDSALL, RL
    INTERNATIONAL JOURNAL OF APPLIED RADIATION AND ISOTOPES, 1975, 26 (10): : 631 - 633
  • [43] Validation of the Monte Carlo simulator GATE for indium-111 imaging
    Assié, K
    Gardin, I
    Véra, P
    Buvat, I
    PHYSICS IN MEDICINE AND BIOLOGY, 2005, 50 (13): : 3113 - 3125
  • [44] Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities
    Inanir, Sabahat
    Ünlü, Mustafa
    Okudan, Berna
    Cila, Erdal
    Atik, Sahap
    European Journal of Nuclear Medicine and Molecular Imaging, 1996, 23 (08) : 987 - 990
  • [45] Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities
    Inanir, S
    Unlu, M
    Okudan, B
    Cila, E
    Atik, S
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (08): : 987 - 990
  • [46] CONJUGATION OF ANTIBODIES WITH COMPOUNDS CAPABLE OF RAPIDLY BINDING INDIUM-111
    PRITCHARD, JH
    ACKERMAN, MJ
    TUBIS, M
    BLAHD, WH
    JOURNAL OF NUCLEAR MEDICINE, 1975, 16 (06) : 559 - 559
  • [47] Auger electron therapeutic effectivness in neuroendocrine and non tumors using indium-111 labelled pentetreotide: Correlation with CT/MRI images
    Limouris, GS
    Vollotopoulos, V
    Lyra, M
    Dimitropoulos, N
    Hatzioannou, A
    Mourikis, D
    RADIOLOGY, 2000, 217 : 413 - 413
  • [48] Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia
    Nguyen, BD
    Wang, EA
    CLINICAL NUCLEAR MEDICINE, 1999, 24 (02) : 130 - 131
  • [49] CURRENT STATUS OF INDIUM-111 LABELED BLEOMYCIN FOR TUMOR DETECTION
    TAYLOR, RD
    BLAHD, WH
    WESTERN JOURNAL OF MEDICINE, 1975, 123 (05): : 386 - 386
  • [50] Indium-111 pentetreotide lung uptake in infectious lung disease
    Castellani, M
    Reschini, E
    Gasparini, M
    Gerundini, P
    CLINICAL NUCLEAR MEDICINE, 1999, 24 (05) : 343 - 345